NASDAQ · Healthcare · Financials
Illumina Inc. (ILMN) Financial Statements: Income, Balance Sheet & Cash Flow
Revenue, profitability, balance-sheet strength, and cash generation for ILMN. SEC filings, statements through Jun 28, 2026.
Section freshness
Prices as of Sep 18, 4:00 PM EDT · Fundamentals checked Sep 20, 5:02 PM EDT · Statements Jun 28, 2026
Financial read
ILMN latest financial snapshot.
Start with the latest reported values below. Deeper quarterly and annual statement tables follow when supplied.
Revenue
$1.16B
+9.4% YoY
Net income
$207.00M
+54.5% QoQ
Free cash flow
$161.00M
-35.9% QoQ
Gross margin
66.44%
Gross profit $770.00M
Balance sheet coverage
ILMN balance sheet summary
Assets, liabilities, liquidity, debt, and equity sit beside income and cash-flow tables so the statement history reads as one model-ready dataset.
20 quarterly · 4 annual rows · Market data source · as of 2026-06-28
Latest period
Q2 FY2026
20 quarterly · 4 annual rows
Assets / liabilities
$6.65B
Liabilities —
Cash / debt
—
Net cash —
Equity / working capital
$2.84B
Working capital $1.26B
Financial statements
ILMN statement coverage.
Income statement, balance sheet, and cash-flow figures for ILMN, with quarterly and annual history in the tables below.
Data last updated
Jun 27, 2026
Income periods
24
Balance-sheet periods
24
Cash-flow periods
24
Quarterly and annual ILMN statements, sourced from SEC filings, statements through Jun 28, 2026.
Financial statement period
ILMN statement history
SEC filings, statements through Jun 28, 2026 · Data last updated: Jun 27, 2026
Income statement
Quarterly and annual rows for revenue, operating leverage, earnings quality, and margin direction.
| Period | Revenue | Gross profit | Operating income | Net income | Net margin | Revenue QoQ | Net income QoQ |
|---|---|---|---|---|---|---|---|
| Q2 FY2026 | $1.16B | $770.00M | $245.00M | $207.00M | 17.86% | +6.2% | +54.5% |
| Q1 FY2026 | $1.09B | $721.00M | $209.00M | $134.00M | 12.28% | -5.9% | -59.9% |
| Q4 FY2025 | $1.16B | $759.00M | $202.00M | $334.00M | 28.82% | +6.9% | +122.7% |
| Q3 FY2025 | $1.08B | $733.00M | $227.00M | $150.00M | 13.84% | +2.4% | -36.2% |
| Q2 FY2025 | $1.06B | $695.00M | $214.00M | $235.00M | 22.19% | +1.7% | +79.4% |
| Q1 FY2025 | $1.04B | $683.00M | $164.00M | $131.00M | 12.58% | -5.7% | -29.6% |
| Q4 FY2024 | $1.10B | $728.00M | $174.00M | $186.00M | 16.85% | +2.2% | -73.6% |
| Q3 FY2024 | $1.08B | $745.00M | $741.00M | $705.00M | 65.28% | -2.9% | +135.5% |
Balance sheet
Balance-sheet history for assets, liabilities, liquidity, debt, equity, and shares outstanding.
| Period | Current assets | Current liabilities | Total assets | Total debt | Total equity |
|---|---|---|---|---|---|
| Q2 FY2026 | $2.83B | $1.58B | $6.65B | $2.84B | |
| Q1 FY2026 | $2.74B | $1.57B | $6.56B | $2.68B | |
| Q4 FY2025 | $3.29B | $1.58B | $6.64B | $2.72B | |
| Q3 FY2025 | $2.80B | $1.96B | $6.18B | $2.38B | |
| Q2 FY2025 | $2.64B | $1.46B | $6.09B | $2.26B | |
| Q1 FY2025 | $2.67B | $1.44B | $6.18B | $2.37B | |
| Q4 FY2024 | $2.75B | $1.55B | $6.30B | $2.37B | |
| Q3 FY2024 | $2.37B | $975.00M | $6.01B | $2.13B |
Cash flow
Operating cash generation, capital expenditure, free cash flow, buybacks, dividends, and cash movement.
| Period | Operating cash flow | CapEx | Free cash flow | Net income | Buybacks | FCF QoQ |
|---|---|---|---|---|---|---|
| Q2 FY2026 | $201.00M | $40.00M | $161.00M | $207.00M | $128.00M | -35.9% |
| Q1 FY2026 | $289.00M | $38.00M | $251.00M | $134.00M | $242.00M | -5.6% |
| Q4 FY2025 | $321.00M | $55.00M | $266.00M | $334.00M | $42.00M | +5.1% |
| Q3 FY2025 | $284.00M | $31.00M | $253.00M | $150.00M | $130.00M | +24.0% |
| Q2 FY2025 | $234.00M | $30.00M | $204.00M | $235.00M | $370.00M | -1.9% |
| Q1 FY2025 | $240.00M | $32.00M | $208.00M | $131.00M | $200.00M | -37.9% |
| Q4 FY2024 | $364.00M | $29.00M | $335.00M | $186.00M | $17.00M | +18.0% |
| Q3 FY2024 | $316.00M | $32.00M | $284.00M | $705.00M | $99.00M | +479.6% |
Valuation and returns
- Return on equity
- 29.07%
- Market data source · as of 2026-09-20
- Return on assets
- 12.41%
- Market data source · as of 2026-09-20
Ratio values use provider-attributed fields when available and otherwise fall back to TECHi statement math from the visible rows on this page.
Annual revenue and income multiples
Annual sales and income multiple reads use the latest annual statement when available, then fall back to trailing-twelve-month statement math from the visible quarterly rows.
- Annual revenue base
- $4.34B
- Annual statement 2025-12-28
- Annual income base
- $850.00M
- Annual statement 2025-12-28
- Market cap / annual revenue
- 8.33
- Live market value divided by annual revenue
- Market cap / annual income
- 42.57
- Live market value divided by annual net income
Market capitalization bridge
TTM valuation multiples
- TTM revenue
- $4.49B
- Trailing twelve months
- TTM EBIT
- $883.00M
- TTM operating income
- Market cap / TTM revenue
- 8.05
- Live market value divided by trailing twelve months revenue
Live market value is matched against trailing-twelve-month statement bases first so the multiple moves with the tape instead of anchoring to stale fiscal-year rows.
Profit multiples
Revenue, net income, and free cash flow
Quarterly statement rows, shown on one common dollar scale so margin compression and cash conversion stand out quickly.
Efficiency
- Revenue / employee
- $522,441.86
- 8,600 employees
- Net income / employee
- $95,930.233
- TTM net income divided by employees
- FCF / employee
- $108,255.814
- TTM free cash flow divided by employees
- Market cap / employee
- $4.21M
- Live value per employee
Growth vs cost pressure
Cash conversion
TTM free cash flow / TTM operating income
Quarterly margin heatmap
Latest quarter expense mix
Profit bridge
Other income statement lines
Balance sheet · Q2 FY2026
- Total equity
- $2.84B
Balance sheet detail
- Current assets
- $2.83B
- Current liabilities
- $1.58B
- Inventory
- $629.00M
- Receivables
- $764.00M
- Property, plant & equipment
- $745.00M
Debt and liquidity
Cash + short-term investments + receivables / current liabilities
Cash generation
- Operating cash flow
- $201.00M
- Capital expenditure
- $40.00M
- Free cash flow
- $161.00M
- Capital returned
- $128.00M
- Buybacks + dividends paid
Cash-flow detail
- Investing cash flow
- -$122.00M
- Financing cash flow
- -$129.00M
- Buybacks
- $128.00M
- Net buybacks
- $128.00M
- Repurchases less stock issuance
Cash flow read
ILMN converts most of its earnings into cash.
Free cash flow of $161.00M versus $207.00M of reported net income means accruals aren't doing much heavy lifting — the cash is showing up alongside the earnings. That's the cleanest profile a fundamentals desk wants to see.
Frequently asked
Common questions.
What financial data is available for ILMN?
TECHi shows Illumina Inc.'s income statement, balance sheet, and cash-flow statement by reported period, with each figure attributed to its source. Line items the company does not report are left blank rather than estimated.
How current are ILMN's financial statements?
Each ILMN statement is labelled with its reported period and source, so you can see exactly which quarter or fiscal year a figure covers and when the data was last updated.
What is Illumina Inc.'s reported net margin?
Illumina Inc. reports a net margin of 18.36% in its latest available fundamentals; the statements below show the revenue and cost lines behind it.